Blood Glucose Monitoring Devices Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Blood Glucose Monitoring Devices Market in 2025 is evaluated at USD 20.85 billion. The global Market size crossed USD 19.31 billion in 2024 and is likely to register a CAGR of over 10%, exceeding USD 66.66 billion revenue by 2037. North America is expected to approach largest share by 2037, attributed to rising cases of diabetes and increasing adoption of advanced blood glucose monitoring devices.
The growth of the market can be attributed to the escalating number of people suffering from diabetes, which needs to be monitored constantly. For instance, in 2021, around 537 million people were diagnosed with diabetes across the globe, and it is expected to increase to 640 million by 2030 and around 783 million by 2045. Further, the growing awareness among people regarding diabetes prevention, followed by the surge in the geriatric population developing diabetes, is also estimated to spur the market growth throughout the projected time frame.
In addition to these, factors that are believed to fuel the market growth of blood glucose monitoring systems include the rise in the stances of obesity among individuals. Since, obesity leads to several kinds of health disorders and diabetes is one of them that affects obese people in a high ratio. Based on a report released by the World Health Organization (WHO) on March 2022, obesity affects more than one billion people globally, comprising 650 million adults, 340 million teenagers, and 39 million children. This figure is still rising. Additionally, the growing ratio of physical inactivity, followed by the family history and genetic mutation, and hormonal disorders can also cause an increased level of blood glucose. Therefore, all of these major factors are predicted to present a prominent expansion to the market’s growth over the projected period.
Blood Glucose Monitoring Devices Sector: Growth Drivers and Challenges
Growth Drivers
-
Increase in the Number of Patients with type-1 or Insulin-Dependent type-2 Diabetes – Glucose monitoring system helps to monitor the diabetes at an earlier stage, so that the proper treatment can be given at right time such human insulin is generally used to control blood sugar level in people dealing with type 1 diabetes or type 2 diabetes. For instance, according to a report in 2021, it was evaluated that the incidence of type-1 diabetes was 149.5 per 1000 children and the global prevalence was around 9.8% among the total population.
- Rising Ubiquity of Diabetes – For instance, in 2021, China, Mexico, India, the United States, and Brazil accounted for around 50% of the global diabetes population.
- Increase in the Number of Patients with type-1 or Insulin-Dependent type-2 Diabetes – For instance, according to a report in 2021, it was evaluated that the incidence of type-1 diabetes was 149.5 per 1000 children and the global prevalence was around 9.8% among the total population.
- Growing Investment in Diabetic Research Activities – In the United States, more than USD 860 million were invested in over 4,800 diabetes research projects over the last 70 years.
- Increasing Access to Health Care and Health Expenditures - As per the data from the World Bank, 9.83% of the global GDP was spent on health expenditures in 2019.
Challenges
-
Lower Diagnosis & Treatment Rate of Diabetes – In developing and underdeveloped countries, a large proportion of people remain undiagnosed owing to a lack of awareness and associated costs. Moreover, lack of access to medical facilities and poor healthcare infrastructure are also major concerns for the lower treatment rates of diabetes in such regions. Therefore, this factor is estimated to hinder blood glucose monitoring devices market growth over the projected time frame.
- Low Reimbursement Policies for the Blood Glucose Monitoring System
- Inadequate Approach to Advanced Healthcare Infrastructure
Blood Glucose Monitoring Devices Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
10% |
|
Base Year Market Size (2024) |
USD 19.31 billion |
|
Forecast Year Market Size (2037) |
USD 66.66 billion |
|
Regional Scope |
|
Blood Glucose Monitoring Devices Segmentation
Product (Self-Monitoring Devices, Continuous Glucose Monitoring Devices)
The global blood glucose monitoring devices market is segmented and analyzed for demand and supply by product into self-monitoring devices, and continuous glucose monitoring devices. Out of these two types of segments, the self-monitoring devices segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the ease of use provided by these devices as people can monitor their blood sugar levels through these devices in the comfort of their homes. Further, the development of novel lancet devices with faster outcomes and less pain for the user is also anticipated to fuel market expansion. For instance, in November 2021, Intuity Medical, Inc., launched the POGO Automatic Monitor, an innovative automatic glucose monitoring device. It utilizes ten-test cartridges that include test strips and lancets instead of depending on separate test strips and lancets. At the touch of a button, the POGO Automatic instantly lances, gathers blood, and provides results in a few seconds.
Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
The global blood glucose monitoring devices market is also segmented and analyzed for demand and supply by disease type into type 1 diabetes, type 2 diabetes, and gestational diabetes. Amongst these three segments, the type 2 diabetes segment is expected to garner a significant share, backed by the rapidly surging prevalence of type 2 diabetes patients throughout the world. As per the World Health Organization report, type 2 diabetes accounts for more than 95% of all diabetes cases worldwide. This, as an outcome, is projected to generate numerous opportunities for the growth of the segment in the coming years.
Our in-depth analysis of the global market includes the following segments:
|
By Product |
|
|
By Modality |
|
|
By Disease Type |
|
|
By Distribution Channel |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Blood Glucose Monitoring Devices Industry - Regional Synopsis
North American Market Forecast
The North America blood glucose monitoring devices market is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the rising cases of diabetes with the prevalence of obesity owing to an inactive lifestyle. For instance, it was estimated that around 32.2 million people in the United States, were suffering from diabetes in 2021. Further, the huge investment in research and development activities, along with the increasing adoption of technologically advanced devices, are some further factors that are anticipated to boost the market growth. In addition, the expanding per capita medical expenditure is also anticipated to drive the market growth further during the projected time frame.
APAC Market Statistics
Further, the Asia Pacific blood glucose monitoring devices market is also estimated to display lucrative revenue by the end of 2037. The growth of the market can be attributed to the large pool of diabetes patients who have been dealing with insulin-dependent diabetes, along with the escalating ratio of aged people in the region. In addition to this, rising awareness about diabetes preventive care, followed by improving healthcare facilities are some more factors that are anticipated to drive the growth of the market in the region throughout the forecast period.
Companies Dominating the Blood Glucose Monitoring Devices Landscape
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- F. Hoffmann-La Roche Ltd
- Ascensia Diabetes Care Holdings AG
- Dexcom, Inc.
- NIPRO CORPORATION
- Prodigy Diabetes Care, LLC
- ACON Laboratories, Inc.
- Insulet Corporation
- Ypsomed AG
- Terumo Corporation
Recent Developments
-
Abbott Laboratories announced new data from the Real-World Evidence of FreeStyle Libre study showing the use of freestyle libre, a continuous glucose monitoring system significantly reduced the rate of hospitalizations.
-
F. Hoffmann-La Roche Ltd launched the cobas pulse system, a connected professional blood glucose management solution that builds on its inheritance with Accu-Chek Inform II. Healthcare professionals working in a variety of care settings can use this handheld blood glucose management device to monitor the blood glucose levels of patients.
Author Credits: Radhika Pawar
- Report ID: 4606
- Published Date: May 08, 2025
- Report Format: PDF, PPT
